• Something wrong with this record ?

NR4A3 fusions characterize a distinctive peritoneal mesothelial neoplasm of uncertain biological potential with pure adenomatoid/microcystic morphology

A. Agaimy, L. Brcic, LM. Briski, YP. Hung, M. Michal, M. Michal, GP. Nielsen, R. Stoehr, AE. Rosenberg

. 2023 ; 62 (5) : 256-266. [pub] 20221225

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc23003614

A focal adenomatoid-microcystic pattern is not uncommon in peritoneal mesothelioma, but tumors composed almost exclusively of this pattern are distinctly rare and have not been well characterized. A small subset of mesotheliomas (mostly in children and young adults) are characterized by gene fusions including EWSR1/FUS::ATF1, EWSR1::YY1, and NTRK and ALK rearrangements, and often have epithelioid morphology. Herein, we describe five peritoneal mesothelial neoplasms (identified via molecular screening of seven histologically similar tumors) that are pure adenomatoid/microcystic in morphology and unified by the presence of an NR4A3 fusion. Patients were three males and two females aged 31-70 years (median, 40 years). Three presented with multifocal/diffuse and two with a localized disease. The size of the individual lesions ranged from 1.5 to 8 cm (median, 4.7). The unifocal lesions originated in the small bowel mesentery and the mesosigmoid. Treatment included surgery, either alone (three) or combined with hyperthermic intraperitoneal chemotherapy (two), and neoadjuvant or adjuvant chemotherapy (one case each). At the last follow-up (6-13 months), all five patients were alive and disease-free. All tumors were morphologically similar, characterized by extensive sieve-like microcystic growth with bland-looking flattened cells lining variably sized microcystic spaces and lacked a conventional epithelioid or sarcomatoid component. Immunohistochemistry confirmed mesothelial differentiation, but most cases showed limited expression of D2-40 and calretinin. Targeted RNA sequencing revealed an NR4A3 fusion (fusion partners were EWSR1 in three cases and CITED2 and NIPBL in one case each). The nosology and behavior of this morphomolecularly defined novel peritoneal mesothelial neoplasm of uncertain biological potential and its distinction from adenomatoid variants of conventional mesothelioma merit further delineation as more cases become recognized.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23003614
003      
CZ-PrNML
005      
20230425140746.0
007      
ta
008      
230418s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/gcc.23118 $2 doi
035    __
$a (PubMed)36524687
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Agaimy, Abbas $u Institute of Pathology, Friedrich Alexander University Erlangen-Nürnberg, University Hospital, Erlangen, Germany $1 https://orcid.org/0000000204458161
245    10
$a NR4A3 fusions characterize a distinctive peritoneal mesothelial neoplasm of uncertain biological potential with pure adenomatoid/microcystic morphology / $c A. Agaimy, L. Brcic, LM. Briski, YP. Hung, M. Michal, M. Michal, GP. Nielsen, R. Stoehr, AE. Rosenberg
520    9_
$a A focal adenomatoid-microcystic pattern is not uncommon in peritoneal mesothelioma, but tumors composed almost exclusively of this pattern are distinctly rare and have not been well characterized. A small subset of mesotheliomas (mostly in children and young adults) are characterized by gene fusions including EWSR1/FUS::ATF1, EWSR1::YY1, and NTRK and ALK rearrangements, and often have epithelioid morphology. Herein, we describe five peritoneal mesothelial neoplasms (identified via molecular screening of seven histologically similar tumors) that are pure adenomatoid/microcystic in morphology and unified by the presence of an NR4A3 fusion. Patients were three males and two females aged 31-70 years (median, 40 years). Three presented with multifocal/diffuse and two with a localized disease. The size of the individual lesions ranged from 1.5 to 8 cm (median, 4.7). The unifocal lesions originated in the small bowel mesentery and the mesosigmoid. Treatment included surgery, either alone (three) or combined with hyperthermic intraperitoneal chemotherapy (two), and neoadjuvant or adjuvant chemotherapy (one case each). At the last follow-up (6-13 months), all five patients were alive and disease-free. All tumors were morphologically similar, characterized by extensive sieve-like microcystic growth with bland-looking flattened cells lining variably sized microcystic spaces and lacked a conventional epithelioid or sarcomatoid component. Immunohistochemistry confirmed mesothelial differentiation, but most cases showed limited expression of D2-40 and calretinin. Targeted RNA sequencing revealed an NR4A3 fusion (fusion partners were EWSR1 in three cases and CITED2 and NIPBL in one case each). The nosology and behavior of this morphomolecularly defined novel peritoneal mesothelial neoplasm of uncertain biological potential and its distinction from adenomatoid variants of conventional mesothelioma merit further delineation as more cases become recognized.
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a adenom $7 D000236
650    _2
$a nádorové biomarkery $x genetika $7 D014408
650    _2
$a proteiny buněčného cyklu $x genetika $7 D018797
650    _2
$a DNA vazebné proteiny $x genetika $7 D004268
650    _2
$a fúze genů $7 D050939
650    _2
$a mezenterium $x patologie $7 D008643
650    12
$a mezoteliom $x genetika $7 D008654
650    12
$a peritoneální nádory $x genetika $x patologie $7 D010534
650    12
$a steroidní receptory $x genetika $7 D011987
650    _2
$a receptory thyreoidních hormonů $x genetika $7 D011988
650    _2
$a represorové proteiny $x genetika $7 D012097
650    _2
$a trans-aktivátory $x genetika $7 D015534
650    _2
$a dospělí $7 D000328
650    _2
$a lidé středního věku $7 D008875
650    _2
$a senioři $7 D000368
655    _2
$a časopisecké články $7 D016428
700    1_
$a Brcic, Luka $u Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria $1 https://orcid.org/0000000290988416
700    1_
$a Briski, Laurence M $u Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA
700    1_
$a Hung, Yin P $u Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA $1 https://orcid.org/0000000285681591
700    1_
$a Michal, Michael $u Department of Pathology, Charles University, Faculty of Medicine in Plzen, Pilsen, Czech Republic
700    1_
$a Michal, Michal $u Department of Pathology, Charles University, Faculty of Medicine in Plzen, Pilsen, Czech Republic
700    1_
$a Nielsen, G Petur $u Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA
700    1_
$a Stoehr, Robert $u Institute of Pathology, Friedrich Alexander University Erlangen-Nürnberg, University Hospital, Erlangen, Germany
700    1_
$a Rosenberg, Andrew E $u Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA
773    0_
$w MED00001898 $t Genes, chromosomes & cancer $x 1098-2264 $g Roč. 62, č. 5 (2023), s. 256-266
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36524687 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425140743 $b ABA008
999    __
$a ok $b bmc $g 1924348 $s 1189823
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 62 $c 5 $d 256-266 $e 20221225 $i 1098-2264 $m Genes, chromosomes & cancer $n Genes Chromosom Cancer $x MED00001898
LZP    __
$a Pubmed-20230418

Find record

Citation metrics

Archiving options